Market Cap 528.90M
Revenue (ttm) 0.00
Net Income (ttm) -74.15M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 145,904
Avg Vol 176,994
Day's Range N/A - N/A
Shares Out 18.87M
Stochastic %K 13%
Beta 3.21
Analysts Strong Sell
Price Target $78.44

Company Profile

Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treat...

Industry: Biotechnology
Sector: Healthcare
Phone: 339 666 3320
Address:
490 Arsenal Way, Suite 210, Watertown, United States
Quantumup
Quantumup Jul. 22 at 12:32 PM
Evercore ISI🏁 $TENX OP-$39 & says that it models a strong 50% PoS—sees upside ranging from +250% (base case data) to 10x (home-run data)—90% downside on failure. $TECX MRK $CYTK EWTX MLYS AZN TNYA Evercore ISI said -- "This is not a conviction call for us. There's not enough data for this to be a conviction call for anyone. That's why the stock is only $1B mkt cap in the context of massive potential upside driven by the huge unmet need in PH-HFpEF. But we spent a lot of time digging in and walked away thinking...this trial has a real shot at working. We model a strong 50% PoS, and see upside ranging from +250% (base case data) to 10x (home-run data) depending on the strength of data; 90% downside on failure. Scenarios below. We calculate that the current trading price implies only ~20 25% odds of LEVEL working. So if you believe TENX has around coin flip odds of this study working, you should find the current stock setup compelling. We're initiating coverage at Outperform with a $39 PT.
0 · Reply
OctahedronOmega
OctahedronOmega Jul. 11 at 4:01 PM
$TECX is a high-risk binary here IMO, especially after $AZN DC’d a similar molecule. Early hemodynamic data looks encouraging, but this disease has been tough to translate into real clinical benefit like 6MWD. I’ve seen this setup before — data can look good, but the market usually wants proof it moves outcomes.
0 · Reply
Danzzzzzzzz
Danzzzzzzzz Jul. 6 at 2:59 PM
$BMEA simple... ​$TNGX ... $1.1 in may 2025. Now around 32. $$EDSA ... 0.73 a few months ago. Rallied up to $20 a couple mobths ago. A few good ones too: $CLYM $RNAC $TECX
1 · Reply
Boastalker
Boastalker Jul. 4 at 8:38 PM
$TECX i’ve been holding onto this one since the stock split so hopefully it’s finally gonna do something for me.
0 · Reply
topstockalerts
topstockalerts Jul. 3 at 8:07 PM
$TECX this one may have caught a lot of people flat-footed
0 · Reply
History101
History101 Jul. 3 at 7:43 PM
$TECX 2,187 watching 7/3/2026
0 · Reply
Doozio
Doozio Jul. 3 at 4:07 PM
$TECX it was always ENTA 🐒🍌🧠⏰♾️
0 · Reply
revuelto
revuelto Jul. 2 at 11:15 PM
$TECX be part of the acquisition story.. 🎉
0 · Reply
ParkerTradesX
ParkerTradesX Jul. 2 at 10:35 PM
$TECX $MRNA $MGTX and a cluster of names just printed fresh 52-week highs, and this is the kind of tape that quietly builds momentum before people realize the trend has already moved. $TECX led the board +16% on heavy volume, no clean catalyst yet, which honestly makes it more interesting than less. Pure price discovery mode. $MRNA +10% and biotech names like MGTX SLDB VRTX all participating, showing this is not a single-name move, it is rotation into higher beta pockets of the market. When breakouts stack like this across different sectors, it usually signals risk appetite is creeping back in even if headlines are quiet. Question is simple. Are you chasing strength or still waiting for confirmation that already came? To my subscribers and future subscribers: When the next bull run starts, this is the type of portfolio performance we are working to build again. Are you going to miss out again?
0 · Reply
vatexas
vatexas Jul. 2 at 2:42 PM
$TECX Excellent..
0 · Reply
Latest News on TECX
Tectonic Therapeutic completes enrollment for APEX trial

2026-06-10T20:06:01.000Z - 7 weeks ago

Tectonic Therapeutic completes enrollment for APEX trial


Tectonic Therapeutic Transcript: AGM 2026

Jun 8, 2026, 9:00 AM EDT - 2 months ago

Tectonic Therapeutic Transcript: AGM 2026


Tectonic Therapeutic Quarterly report: Q1 2026

May 7, 2026, 7:00 AM EDT - 3 months ago

Tectonic Therapeutic Quarterly report: Q1 2026


Tectonic Therapeutic Earnings release: Q1 2026

May 7, 2026, 7:00 AM EDT - 3 months ago

Tectonic Therapeutic Earnings release: Q1 2026


Tectonic Therapeutic Slides: Investor presentation

May 7, 2026, 7:00 AM EDT - 3 months ago

Tectonic Therapeutic Slides: Investor presentation


Tectonic Therapeutic management to meet with Piper Sandler

2026-04-27T19:55:13.000Z - 3 months ago

Tectonic Therapeutic management to meet with Piper Sandler


Tectonic Therapeutic Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 3 months ago

Tectonic Therapeutic Proxy statement: Proxy filing


Tectonic Therapeutic Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 3 months ago

Tectonic Therapeutic Proxy statement: Proxy filing


Tectonic Therapeutic initiated with a Buy at Stifel

2026-04-13T20:16:05.000Z - 4 months ago

Tectonic Therapeutic initiated with a Buy at Stifel


Tectonic Therapeutic Earnings release: Q4 2025

Feb 26, 2026, 3:00 PM EST - 5 months ago

Tectonic Therapeutic Earnings release: Q4 2025


Tectonic Therapeutic Annual report: Q4 2025

Feb 26, 2026, 3:00 PM EST - 5 months ago

Tectonic Therapeutic Annual report: Q4 2025


Tectonic Therapeutic Transcript: KOL event

Feb 24, 2026, 11:00 AM EST - 5 months ago

Tectonic Therapeutic Transcript: KOL event


Tectonic Therapeutic Slides: KOL event

Feb 24, 2026, 11:00 AM EST - 5 months ago

Tectonic Therapeutic Slides: KOL event


Tectonic Therapeutic reports Q3 EPS ($1.02), consensus ($1.05)

2025-11-06T21:11:24.000Z - 9 months ago

Tectonic Therapeutic reports Q3 EPS ($1.02), consensus ($1.05)


Tectonic Therapeutic Quarterly report: Q3 2025

Nov 6, 2025, 4:00 PM EST - 9 months ago

Tectonic Therapeutic Quarterly report: Q3 2025


Tectonic Therapeutic Earnings release: Q3 2025

Nov 6, 2025, 4:00 PM EST - 9 months ago

Tectonic Therapeutic Earnings release: Q3 2025


Tectonic Therapeutic Inc trading resumes

2025-10-29T20:35:16.000Z - 9 months ago

Tectonic Therapeutic Inc trading resumes


Tectonic Therapeutic Transcript: Study Result

Oct 29, 2025, 4:30 PM EDT - 9 months ago

Tectonic Therapeutic Transcript: Study Result


Tectonic Therapeutic Press release: Study Result

Oct 29, 2025, 4:30 PM EDT - 9 months ago

Tectonic Therapeutic Press release: Study Result


Tectonic Therapeutic Slides: Study Result

Oct 29, 2025, 4:30 PM EDT - 9 months ago

Tectonic Therapeutic Slides: Study Result


Tectonic Therapeutic Inc trading halted, news pending

2025-10-29T20:07:43.000Z - 9 months ago

Tectonic Therapeutic Inc trading halted, news pending


Tectonic Therapeutic initiated with an Outperform at Oppenheimer

2025-09-03T10:15:30.000Z - 11 months ago

Tectonic Therapeutic initiated with an Outperform at Oppenheimer


Tectonic Therapeutic Earnings release: Q2 2025

Aug 7, 2025, 4:00 PM EDT - 1 year ago

Tectonic Therapeutic Earnings release: Q2 2025


Tectonic Therapeutic Quarterly report: Q2 2025

Aug 7, 2025, 4:00 PM EDT - 1 year ago

Tectonic Therapeutic Quarterly report: Q2 2025


Tectonic Therapeutic initiated with a Buy at Truist

2025-07-21T10:31:06.000Z - 1 year ago

Tectonic Therapeutic initiated with a Buy at Truist


Tectonic Therapeutic files $400M mixed securities shelf

2025-07-07T21:55:15.000Z - 1 year ago

Tectonic Therapeutic files $400M mixed securities shelf


Tectonic Therapeutic joins Russell 3000 Index

2025-06-30T14:31:19.000Z - 1 year ago

Tectonic Therapeutic joins Russell 3000 Index


Tectonic Therapeutic Joins Russell 3000® Index

Jun 30, 2025, 8:00 AM EDT - 1 year ago

Tectonic Therapeutic Joins Russell 3000® Index


Tectonic Therapeutic Quarterly report: Q1 2025

May 8, 2025, 12:00 AM EDT - 1 year ago

Tectonic Therapeutic Quarterly report: Q1 2025


Tectonic Therapeutic Earnings release: Q1 2025

May 8, 2025, 12:00 AM EDT - 1 year ago

Tectonic Therapeutic Earnings release: Q1 2025


Tectonic Therapeutic Annual report: Q4 2024

Mar 20, 2025, 4:00 PM EDT - 1 year ago

Tectonic Therapeutic Annual report: Q4 2024


Tectonic Therapeutic Earnings release: Q4 2024

Mar 20, 2025, 4:00 PM EDT - 1 year ago

Tectonic Therapeutic Earnings release: Q4 2024


Tectonic Announces $185 Million Private Placement

Feb 3, 2025, 6:30 AM EST - 1 year ago

Tectonic Announces $185 Million Private Placement


Tectonic Therapeutic Transcript: Status Update

Dec 12, 2024, 4:00 PM EST - 1 year ago

Tectonic Therapeutic Transcript: Status Update


Tectonic Therapeutic Slides: Status Update

Dec 12, 2024, 4:00 PM EST - 1 year ago

Tectonic Therapeutic Slides: Status Update


Tectonic Therapeutic Quarterly report: Q3 2024

Nov 6, 2024, 6:00 PM EST - 1 year ago

Tectonic Therapeutic Quarterly report: Q3 2024


Tectonic Therapeutic Earnings release: Q3 2024

Nov 6, 2024, 6:00 PM EST - 1 year ago

Tectonic Therapeutic Earnings release: Q3 2024


Tectonic Therapeutic to Present Phase 1a Data at AHA 2024

Oct 22, 2024, 4:01 PM EDT - 1 year ago

Tectonic Therapeutic to Present Phase 1a Data at AHA 2024


Tectonic Therapeutic Quarterly report: Q2 2024

Aug 13, 2024, 6:00 PM EDT - 2 years ago

Tectonic Therapeutic Quarterly report: Q2 2024


Tectonic Therapeutic Earnings release: Q2 2024

Aug 13, 2024, 6:00 PM EDT - 2 years ago

Tectonic Therapeutic Earnings release: Q2 2024


Quantumup
Quantumup Jul. 22 at 12:32 PM
Evercore ISI🏁 $TENX OP-$39 & says that it models a strong 50% PoS—sees upside ranging from +250% (base case data) to 10x (home-run data)—90% downside on failure. $TECX MRK $CYTK EWTX MLYS AZN TNYA Evercore ISI said -- "This is not a conviction call for us. There's not enough data for this to be a conviction call for anyone. That's why the stock is only $1B mkt cap in the context of massive potential upside driven by the huge unmet need in PH-HFpEF. But we spent a lot of time digging in and walked away thinking...this trial has a real shot at working. We model a strong 50% PoS, and see upside ranging from +250% (base case data) to 10x (home-run data) depending on the strength of data; 90% downside on failure. Scenarios below. We calculate that the current trading price implies only ~20 25% odds of LEVEL working. So if you believe TENX has around coin flip odds of this study working, you should find the current stock setup compelling. We're initiating coverage at Outperform with a $39 PT.
0 · Reply
OctahedronOmega
OctahedronOmega Jul. 11 at 4:01 PM
$TECX is a high-risk binary here IMO, especially after $AZN DC’d a similar molecule. Early hemodynamic data looks encouraging, but this disease has been tough to translate into real clinical benefit like 6MWD. I’ve seen this setup before — data can look good, but the market usually wants proof it moves outcomes.
0 · Reply
Danzzzzzzzz
Danzzzzzzzz Jul. 6 at 2:59 PM
$BMEA simple... ​$TNGX ... $1.1 in may 2025. Now around 32. $$EDSA ... 0.73 a few months ago. Rallied up to $20 a couple mobths ago. A few good ones too: $CLYM $RNAC $TECX
1 · Reply
Boastalker
Boastalker Jul. 4 at 8:38 PM
$TECX i’ve been holding onto this one since the stock split so hopefully it’s finally gonna do something for me.
0 · Reply
topstockalerts
topstockalerts Jul. 3 at 8:07 PM
$TECX this one may have caught a lot of people flat-footed
0 · Reply
History101
History101 Jul. 3 at 7:43 PM
$TECX 2,187 watching 7/3/2026
0 · Reply
Doozio
Doozio Jul. 3 at 4:07 PM
$TECX it was always ENTA 🐒🍌🧠⏰♾️
0 · Reply
revuelto
revuelto Jul. 2 at 11:15 PM
$TECX be part of the acquisition story.. 🎉
0 · Reply
ParkerTradesX
ParkerTradesX Jul. 2 at 10:35 PM
$TECX $MRNA $MGTX and a cluster of names just printed fresh 52-week highs, and this is the kind of tape that quietly builds momentum before people realize the trend has already moved. $TECX led the board +16% on heavy volume, no clean catalyst yet, which honestly makes it more interesting than less. Pure price discovery mode. $MRNA +10% and biotech names like MGTX SLDB VRTX all participating, showing this is not a single-name move, it is rotation into higher beta pockets of the market. When breakouts stack like this across different sectors, it usually signals risk appetite is creeping back in even if headlines are quiet. Question is simple. Are you chasing strength or still waiting for confirmation that already came? To my subscribers and future subscribers: When the next bull run starts, this is the type of portfolio performance we are working to build again. Are you going to miss out again?
0 · Reply
vatexas
vatexas Jul. 2 at 2:42 PM
$TECX Excellent..
0 · Reply
Quantumup
Quantumup Jun. 24 at 12:32 PM
Cantor reiterated $TENX Overweight; $35 and said: Interest in TENX is back...and just in time as we move into 3Q26. $TECX $MRK CYTK EWTX MLYS AZN TNYA Cantor added—TENX is shaping up to be one of the bigger cardiovascular catalysts of the year, with phase 3 LEVEL data for TNX-103 in PH-HFpEF expected in 3Q26. And it's a setup we like (although it's a binary one). TENX will report topline results from LEVEL, its pivotal phase 3 study evaluating oral levosimendan (TNX-103) in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (PH-HFpEF).
0 · Reply
Quantumup
Quantumup Jun. 22 at 11:43 AM
Guggenheim⬆️ $TENX-$40,⬆️PoS, reiterated Buy and said it sees a pot'l >200% move. $TECX MRK $MLYS AZN CYTK EWTX TNYA Here's what Guggenheim said in its note: https://x.com/Quantumup1/status/2069023120770375960?s=20
0 · Reply
Quantumup
Quantumup Jun. 12 at 12:52 PM
Piper Sandler⬆️ $TENX's PT to $50 (was $20), reiterated Overweight and said: With Ph3 LEVEL Coming in 3Q26, Here's Why Now Is The Time to Own & PT Update $TECX MRK AZN CYTK TNYA $MLYS Here's what else Piper Sandler had to say in its note to investors: https://x.com/Quantumup1/status/2065416152172425604?s=20
0 · Reply
AnalyticaInvestor
AnalyticaInvestor Jun. 11 at 10:15 AM
$KEQU $XCUR $TECX $HUMA Good morning, investors. Rising tensions surrounding Iran are pushing energy prices higher and adding another layer of volatility to markets. Attention now turns to inflation data, Federal Reserve expectations, and upcoming earnings reports. Rising input costs remain a key concern, particularly for companies with weaker pricing power and tighter margins. Read the full Analytica Alpha 👇 https://analyticainvestor.beehiiv.com/p/hot-cpi-iran-risk-selloff
0 · Reply
TwinTurboBul161
TwinTurboBul161 Jun. 4 at 10:57 PM
$TECX Dilution risk remains structural-
0 · Reply
Quantumup
Quantumup Jun. 1 at 12:36 PM
Piper Sandler reiterated $TENX Overweight; $20 and said: We hosted TENX mgmt on the road for productive investor meetings in Boston and NYC as we head into TNX-103's highly anticipated 12-week Ph3 LEVEL PH-HFpEF topline in 3Q26. $TECX MRK AZN $CYTK MLYS TNYA Here's what else Piper Sandler had to say: https://x.com/Quantumup1/status/2061426166888575283?s=20
0 · Reply
Quantumup
Quantumup May. 26 at 10:43 AM
Raymond James⬆️ $TECX to Strong Buy-$81 from Outperform-$76 $TENX IBIO AZN $MRK Raymond James said: Tectonic offers an uncommonly attractive opportunity trading at an EV of ~$300M with two potential blockbuster clinical-stage pipeline assets; cash of $237M ($12/sh) supports a runway into late 2028. While TX45 and TX2100 will need incremental de-risking for investors to realize a major upside valuation reset, the potential is clearly there as both programs are built on solid biological rationale and address areas of major unmet need with incremental PoC expected for both programs within the next 12-18 months.
0 · Reply
notreload_ai
notreload_ai May. 26 at 9:37 AM
Raymond James upgraded $TECX to Strong Buy and raised its price target to $81. Analyst highlights the potential of TX45 and TX2100 as two blockbuster candidates at a low valuation. https://notreload.xyz/xy/tectonic-therapeutics-gets-strong-buy-upgrade-two-potential-blockbusters-in-focus/
0 · Reply
SuperGreenToday
SuperGreenToday May. 21 at 7:32 PM
$TECX Share Price: $28.43 Contract Selected: Oct 16, 2026 $30 Calls Buy Zone: $4.67 – $5.78 Target Zone: $8.21 – $10.03 Potential Upside: 66% ROI Time to Expiration: 147 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Tjcmd
Tjcmd May. 8 at 10:53 PM
$TECX FYI
0 · Reply
revuelto
revuelto May. 5 at 2:16 PM
$TECX grossly undervalued
0 · Reply
Ron_Burn
Ron_Burn Apr. 30 at 8:51 AM
$TECX will she hold at support?
0 · Reply